Notice Regarding Completion of Payment for Issuance of the 27th Series Stock Acquisition Rights by Third-Party Allotment (with Exercise Price Adjustment Clause, mNAV Clause, Lower Limit Exercise Price Adjustment Clause, and Exercise Suspension Clause)

Overview of Capital Policy

On April 1, 2026, the Company announced the issuance of 1,000,000 units of the 27th Series Stock Acquisition Rights by third-party allotment to EVO FUND (with each stock acquisition right convertible into 100 shares of common stock), and completion of payment totaling JPY 20,000,000. As a result, the number of potential shares stands at 100,000,000 shares. The amount of funds raised is approximately JPY 37,135,880,000, with the exercise price initially set at JPY 373 and the lower limit exercise price initially at JPY 298. The exercise price is subject to adjustment according to market price fluctuations, and adjustments to the lower limit exercise price can be made by resolution of the Board of Directors, provided it does not fall below JPY 187.

Impact on Shareholders and Other Conditions

The exercise period for these stock acquisition rights is from April 16, 2026, to April 17, 2028. Transfer of these rights by the allottee requires approval from the Company's Board of Directors. The amount of funds raised includes the total payment amount plus the value of contributed assets at the time of exercise minus issuance-related expenses, and may fluctuate due to adjustments of the exercise price or cancellation of the stock acquisition rights. Because this may result in share dilution, investors should monitor future stock price trends and exercise status closely.